LIQUIDIA CORPORATION's ticker is LQDA and the CUSIP is 53635D202. A total of 93 filers reported holding LIQUIDIA CORPORATION in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55 | -27.6% | 8,548 | -11.3% | 0.00% | – |
| Q2 2023 | $76 | -54.8% | 9,632 | -60.2% | 0.00% | – |
| Q1 2023 | $168 | +104.9% | 24,220 | +87.8% | 0.00% | – |
| Q4 2022 | $82 | -99.3% | 12,900 | +511.7% | 0.00% | – |
| Q3 2022 | $11,000 | +10.0% | 2,109 | -11.9% | 0.00% | – |
| Q2 2022 | $10,000 | 0.0% | 2,394 | -36.6% | 0.00% | – |
| Q3 2021 | $10,000 | -50.0% | 3,775 | -45.6% | 0.00% | – |
| Q2 2021 | $20,000 | -67.2% | 6,944 | -69.3% | 0.00% | – |
| Q1 2021 | $61,000 | +134.6% | 22,648 | +159.0% | 0.00% | – |
| Q4 2020 | $26,000 | -58.7% | 8,745 | -31.4% | 0.00% | – |
| Q3 2020 | $63,000 | -33.7% | 12,757 | +13.9% | 0.00% | – |
| Q2 2020 | $95,000 | +352.4% | 11,203 | +151.8% | 0.00% | – |
| Q1 2020 | $21,000 | -63.2% | 4,450 | -66.9% | 0.00% | – |
| Q4 2019 | $57,000 | +128.0% | 13,426 | +95.7% | 0.00% | – |
| Q3 2019 | $25,000 | -63.8% | 6,862 | -20.7% | 0.00% | – |
| Q2 2019 | $69,000 | +1.5% | 8,655 | +45.3% | 0.00% | – |
| Q1 2019 | $68,000 | +36.0% | 5,958 | +226.1% | 0.00% | – |
| Q3 2018 | $50,000 | – | 1,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 9,243,627 | $72,562,472 | 40.81% |
| Kynam Capital Management, LP | 1,642,244 | $12,891,615 | 1.77% |
| HARBERT FUND ADVISORS, INC. | 339,158 | $2,662,390 | 1.49% |
| Opaleye Management Inc. | 570,700 | $4,479,995 | 1.07% |
| Eversept Partners, LP | 925,444 | $7,264,735 | 0.61% |
| Diametric Capital, LP | 155,176 | $1,218,132 | 0.54% |
| Parkman Healthcare Partners LLC | 281,134 | $2,206,902 | 0.38% |
| SkyView Investment Advisors, LLC | 110,000 | $864 | 0.22% |
| Portolan Capital Management | 235,096 | $1,845,504 | 0.16% |
| Soleus Capital Management, L.P. | 175,000 | $1,373,750 | 0.15% |